Literature DB >> 22825329

Regulation of oncogene-induced cell cycle exit and senescence by chromatin modifiers.

Gregory David1.   

Abstract

Oncogene activation leads to dramatic changes in numerous biological pathways controlling cellular division, and results in the initiation of a transcriptional program that promotes transformation. Conversely, it also triggers an irreversible cell cycle exit called cellular senescence, which allows the organism to counteract the potentially detrimental uncontrolled proliferation of damaged cells. Therefore, a tight transcriptional control is required at the onset of oncogenic signal, coordinating both positive and negative regulation of gene expression. Not surprisingly, numerous chromatin modifiers contribute to the cellular response to oncogenic stress. While these chromatin modifiers were initially thought of as mere mediators of the cellular response to oncogenic stress, recent studies have uncovered a direct and specific regulation of chromatin modifiers by oncogenic signals. We review here the diverse functions of chromatin modifiers in the cellular response to oncogenic stress, and discuss the implications of these findings on the regulation of cell cycle progression and proliferation by activated oncogenes.

Mesh:

Substances:

Year:  2012        PMID: 22825329      PMCID: PMC3461821          DOI: 10.4161/cbt.21116

Source DB:  PubMed          Journal:  Cancer Biol Ther        ISSN: 1538-4047            Impact factor:   4.742


  97 in total

1.  Native E2F/RBF complexes contain Myb-interacting proteins and repress transcription of developmentally controlled E2F target genes.

Authors:  Michael Korenjak; Barbie Taylor-Harding; Ulrich K Binné; John S Satterlee; Olivier Stevaux; Rein Aasland; Helen White-Cooper; Nick Dyson; Alexander Brehm
Journal:  Cell       Date:  2004-10-15       Impact factor: 41.582

Review 2.  Histone modifying enzymes and cancer: going beyond histones.

Authors:  Ke Zhang; Sharon Y R Dent
Journal:  J Cell Biochem       Date:  2005-12-15       Impact factor: 4.429

3.  Eaf3 chromodomain interaction with methylated H3-K36 links histone deacetylation to Pol II elongation.

Authors:  Amita A Joshi; Kevin Struhl
Journal:  Mol Cell       Date:  2005-12-22       Impact factor: 17.970

4.  A biomarker that identifies senescent human cells in culture and in aging skin in vivo.

Authors:  G P Dimri; X Lee; G Basile; M Acosta; G Scott; C Roskelley; E E Medrano; M Linskens; I Rubelj; O Pereira-Smith
Journal:  Proc Natl Acad Sci U S A       Date:  1995-09-26       Impact factor: 11.205

5.  Oncogenic ras provokes premature cell senescence associated with accumulation of p53 and p16INK4a.

Authors:  M Serrano; A W Lin; M E McCurrach; D Beach; S W Lowe
Journal:  Cell       Date:  1997-03-07       Impact factor: 41.582

6.  A novel role for high-mobility group a proteins in cellular senescence and heterochromatin formation.

Authors:  Masashi Narita; Masako Narita; Valery Krizhanovsky; Sabrina Nuñez; Agustin Chicas; Stephen A Hearn; Michael P Myers; Scott W Lowe
Journal:  Cell       Date:  2006-08-11       Impact factor: 41.582

7.  DNA damage signaling triggers degradation of histone methyltransferases through APC/C(Cdh1) in senescent cells.

Authors:  Akiko Takahashi; Yoshinori Imai; Kimi Yamakoshi; Shinji Kuninaka; Naoko Ohtani; Shin Yoshimoto; Satoshi Hori; Makoto Tachibana; Emma Anderton; Takashi Takeuchi; Yoichi Shinkai; Gordon Peters; Hideyuki Saya; Eiji Hara
Journal:  Mol Cell       Date:  2011-12-15       Impact factor: 17.970

8.  Sin3B: an essential regulator of chromatin modifications at E2F target promoters during cell cycle withdrawal.

Authors:  Kathryn B Grandinetti; Gregory David
Journal:  Cell Cycle       Date:  2008-04-01       Impact factor: 4.534

9.  Rb-mediated heterochromatin formation and silencing of E2F target genes during cellular senescence.

Authors:  Masashi Narita; Sabrina Nũnez; Edith Heard; Masako Narita; Athena W Lin; Stephen A Hearn; David L Spector; Gregory J Hannon; Scott W Lowe
Journal:  Cell       Date:  2003-06-13       Impact factor: 41.582

10.  Dynamic assembly of chromatin complexes during cellular senescence: implications for the growth arrest of human melanocytic nevi.

Authors:  Debdutta Bandyopadhyay; Jonathan L Curry; Qiushi Lin; Hunter W Richards; Dahu Chen; Peter J Hornsby; Nikolai A Timchenko; Estela E Medrano
Journal:  Aging Cell       Date:  2007-06-18       Impact factor: 9.304

View more
  6 in total

Review 1.  The potential of targeting Sin3B and its associated complexes for cancer therapy.

Authors:  David J Cantor; Gregory David
Journal:  Expert Opin Ther Targets       Date:  2017-10-09       Impact factor: 6.902

Review 2.  Chromatin maintenance and dynamics in senescence: a spotlight on SAHF formation and the epigenome of senescent cells.

Authors:  Armelle Corpet; Manuel Stucki
Journal:  Chromosoma       Date:  2014-05-27       Impact factor: 4.316

Review 3.  Senescent cells: a therapeutic target for cardiovascular disease.

Authors:  Bennett G Childs; Hu Li; Jan M van Deursen
Journal:  J Clin Invest       Date:  2018-04-02       Impact factor: 14.808

4.  Transcriptional repression of Sin3B by Bmi-1 prevents cellular senescence and is relieved by oncogene activation.

Authors:  Teresa DiMauro; David J Cantor; Anthony J Bainor; Gregory David
Journal:  Oncogene       Date:  2014-09-29       Impact factor: 9.867

5.  Senescence Inducer Shikonin ROS-Dependently Suppressed Lung Cancer Progression.

Authors:  Hongming Zheng; Qiuju Huang; Suchao Huang; Xia Yang; Ting Zhu; Wensheng Wang; Haojia Wang; Shugui He; Liyan Ji; Ying Wang; Xiaoxiao Qi; Zhongqiu Liu; Linlin Lu
Journal:  Front Pharmacol       Date:  2018-05-23       Impact factor: 5.810

6.  The role of cellular senescence in the gastrointestinal mucosa.

Authors:  Joshua D Penfield; Marlys Anderson; Lori Lutzke; Kenneth K Wang
Journal:  Gut Liver       Date:  2013-05-13       Impact factor: 4.519

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.